Page last updated: 2024-11-07

2-methyl-5,6-cyclopentapyrimidine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2-methyl-5,6-cyclopentapyrimidine: structure given in first source; RN given is CAS no. reported in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID160264
SCHEMBL ID11561562
MeSH IDM0209993

Synonyms (11)

Synonym
2-methyl-5,6-trimethylenepyrimidine
5h-cyclopentapyrimidine, 6,7-dihydro-2-methyl-
2-methyl-5,6-cyclopentapyrimidine
2-methyl-6,7-dihydro-5h-cyclopentapyrimidine
ccris 6513
6,7-dihydro-2-methyl-5h-cyclopentapyrimidine
2-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidine
36274-29-0
AKOS006277956
SCHEMBL11561562
DTXSID90189818

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" The material was highly toxic by inhalation, with the approximate lethal concentration in rats following single 4-h exposures being 9 ppm."( Toxicity of 2-methyl-5,6-cyclopentapyrimidine (MCPP).
Kennedy, GL, 1992
)
0.66
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's2 (40.00)29.6817
2010's1 (20.00)24.3611
2020's1 (20.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 13.04

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index13.04 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.83 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (13.04)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]